BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) Stock Overview
Explore BioMarin Pharmaceutical Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12.1B
P/E Ratio
456.26
EPS (TTM)
$2.69
ROE
0.00%
BMRN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of BioMarin Pharmaceutical Inc. (BMRN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $39.23.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 456.26 and a market capitalization of 12.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.